new oral glp 1 agonist Not an April fool's prank! The small molecule GLP-1 receptor agonist, orforglipron, has been approved by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode GLP-1 Receptor Agonist Market Size

Supercharge your body's defenses against cold & flu

Licensed Peptides Peptide Research in Neurological Disorders: Innovative Strategies for Alzheimers and Parkinsons Licensed Peptides Licensed Peptides Pure Results, Backed by Science

For example, a randomized crossover trial of L-theanine and Lactium found significant improvements in total sleep score, sleep latency, sleep duration, sleep habitual efficiency, daytime dysfunction, and total and frontal alpha power.65 And animal research suggests an equally profound synergy between L-theanine and magnesium.66 If you want to take L-theanine in an effort to increase focus, no option that weve found on the market would do better than Innerbody Labs Focus Support

Such studies would facilitate the development of risk-stratified guidelines, enabling clinicians to better predict and manage potential interactions in real-world settings

Ask whether third-party results are available

Abu Taher S, Hasan Mahmud R, Nabila T, Biswajit S, Anayt U, et al